Separation of cresol from mare's urine

Details for Australian Patent Application No. 2002213963 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Wilbrand, Kirsten; Rasche, HeinzHelmer; Woltmann, Kerstin

Agent Watermark

Pub. Number AU-B-2002213963

PCT Pub. Number WO02/26760

Priority 100 48 524.3 29.09.00 DE

Filing date 26 September 2001

Wipo publication date 8 April 2002

Acceptance publication date 31 May 2007

International Classifications

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

Event Publications

31 May 2007 Application Accepted

  Published as AU-B-2002213963

27 September 2007 Standard Patent Sealed

26 July 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee name from Solvay Pharmaceuticals GmbH to Abbott Products GmbH . Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002213964

2002213962-Laser emitter